Accord Logo

Intended for UK patients and members of the public

SmPC- Telmisartan/Hydrochlorothiazide 40mg/12.5mg Tablets: Change history

Back to products
  • View Summary of Product Characteristics (SmPC- Telmisartan/Hydrochlorothiazide 40mg/12.5mg Tablets)

    Last updated on this site: 13 May 2025

    Update to SmPC sections 4.4, 4.8 and PIL sections 2 and 4 in line with PRAC recommendations (EPITT No 20104) for intestinal angioedema.

    View change history

    • Changes: (Updated: 13 May 2025)

      Update to SmPC sections 4.4, 4.8 and PIL sections 2 and 4 in line with PRAC recommendations (EPITT No 20104) for intestinal angioedema.

    • Changes: (Updated: 14 Apr 2023)

      Variation description: Type IB (C.I.3.z) variation application to update SmPC section 5.3 for `incresed risk of skin cancer' as per CMDh minutes for the meeting updated on 8-10 November 2022.

      SmPC sections updated: 5.3, 9, 10.

    • Changes: (Updated: 22 Sep 2022)

      initial upload

    Back to Top

    View product information as a: